National Audit Office -
The failure of Greensill Capital in March 2021 has triggered several reviews and investigations. This investigation examines Greensill Capital’s involvement in the provision of two schemes to the NHS – firstly, supply chain finance – with particular focus on the Pharmacy Earlier Payment Scheme to pharmacy contractors; and secondly, the Employer Salary Advance Scheme which allowed NHS employees to access their earned salaries in advance of payday. Supply chain finance is a financial transaction whereby a lender finances a supplier on behalf of the customer. The investigation also considers the impact of the failure of Greensill Capital in March 2021 on the government, taxpayers, and NHS organisations to which it provided its services.